Parathyroid Disease
9
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
85.7%
-0.8% vs benchmark
11%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy
Establishment of a Parathyroid Tissue Bank
Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Gene Expression in Hyperparathyroidism
Complications of Endocrine Surgery: Data From the United HealthSystem Consortium
Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease
Genetic Evaluation of Families With Endocrine Cancers
Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
Lidocaine Supplement for Minimal Invasive Parathyroid Surgery